In this video, Prof. Dr. Robert Hoepner and Univ.-Prof. Dr. med. Julia Weinmann-Menke explain what CAR‑T cell therapy is, which patients may be eligible for it, and what risks are involved. They describe the complex treatment process—from the initial blood draw to the manufacturing of CAR‑T cells, their reinfusion, and the close medical monitoring that follows. They also explain what patients can expect during the therapy and whether additional medication is required afterwards.
Eine deutsche Version des Videos finden Sie hier.
A german version of this video is accessible here.
